Targeting of TAMs: can we be more clever than cancer cells?

Nature·Nov 8

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is being conducted on tumor-associated macrophages (TAMs) and their role in cancer. Studies are exploring various aspects of TAMs, including their polarization, the impact of different therapies, and their interaction with the tumor microenvironment. The findings of these studies may lead to new approaches to targeting TAMs and ultimately to improved cancer treatments.

Full coverage

The Role of Hypoxia-Regulated MicroRNAs (Hypoxamirs) in Tumor-Associated Macrophage Polarization: A Systematic Review

Cureus·May 28

Holding cancer in line: the role of the electron transport chain in tumor-associated macrophages

Frontiers·Feb 23

CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages

Nature·Apr 9

Immune checkpoint inhibitor therapy for gastric cancer: current status, therapeutic challenges, and future prospects

Frontiers·Feb 17

The authors respond to feedback on Cancer Cell-Memory Macrophage Hybrid Theory for metastatic cancer cells

Frontiers·Feb 16

Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy

Nature·Feb 2

TAM Plasticity under androgen deprivation therapy and PARP inhibition in prostate cancer: a multi-omics perspective

Frontiers·Dec 17

Chemokine ligand 2: beyond chemotaxis—a multifaceted role in tumor progression

Frontiers·Oct 29

View original report at Nature ↗

Fetching the latest headlines…